De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney disease

CEN Case Rep. 2024 Dec;13(6):434-439. doi: 10.1007/s13730-024-00864-4. Epub 2024 Mar 23.

Abstract

A 63-year-old man with polycystic kidney disease underwent kidney transplantation from his wife. Nine years later, after the first and second doses of the COVID-19 vaccination, he developed proteinuria, hematuria, and elevated C-reactive protein. Kidney biopsy 7 months after the initial appearance of proteinuria showed immunoglobulin (Ig)-G granular stain, predominantly IgG1, and spike formation in the glomerular basement membrane. Electron microscopy revealed mainly subepithelial deposits, which corresponds to membranous nephropathy (MN) stage 3 of the Ehrenreich-Churg classification indicating chronic disease, but it also showed electron-dense deposits and endothelial damage. Because a kidney biopsy was performed 1 h after renal transplantation and a biopsy of the patient's native kidney showed intact glomeruli, atypical de novo posttransplant membranous nephropathy (MN) was diagnosed, and a close relationship with COVID-19 vaccination was assumed. Clinicians should consider the involvement of COVID-19 vaccination in de novo posttransplant MN with unclear pathogenesis.

Keywords: COVID-19 vaccination; De novo posttransplant membranous nephropathy; Kidney transplantation.

Publication types

  • Case Reports

MeSH terms

  • Biopsy
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / complications
  • COVID-19* / prevention & control
  • Glomerulonephritis, Membranous* / etiology
  • Glomerulonephritis, Membranous* / pathology
  • Humans
  • Kidney Transplantation* / adverse effects
  • Male
  • Middle Aged
  • Polycystic Kidney Diseases* / complications
  • Polycystic Kidney Diseases* / surgery
  • Postoperative Complications / etiology
  • Proteinuria / etiology
  • Vaccination / adverse effects

Substances

  • COVID-19 Vaccines